manmonthly.com.auOCT 122 min read$CCEP

Coca-Cola invests $39.7m in Kewdale plant

Coca-Cola Europacific Partners invested $39.7m in its Kewdale plant, adding a can line to boost capacity by 40%. The upgrade supports local demand, efficiency, and jobs, with the line producing 16m cases annually. The company also launched a workforce pilot for flexible part-time roles, attracting 900 applicants.

Original reporting

manmonthly.com.au

Published Oct 12, 2026, 11:23 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Oct 12, 2026, 11:35 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefCorporate actions

Primary signal

$CCEP

Bullish

high confidence

Mentioned

$CCEP

Relevance

6/10

AlphAI data visualization · based on manmonthly.com.au

Decision brief

The 30-second read

$CCEPBullishLow

Why it matters

The new line improves automation, water and energy efficiency, and positions the Kewdale plant as a flagship facility.

Market read

A fresh capex announcement that could modestly improve CCEP's long‑term earnings and capacity outlook.

What to watch

Potential supply‑chain constraints or higher input costs could offset capacity gains.

Relevance 6/10Novelty 6/10Timing: today

Background

Coca-Cola Europacific Partners is the bottler for Coca-Cola products in the Asia‑Pacific region.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$CCEPBullishHigh confidence

Context

Coca-Cola Europacific Partners announced a $39.7 million investment to add a new can line at its Kewdale plant, increasing capacity by >40%.

Expected impact

potential modest upside as the market prices in higher future capacity and revenue growth

Evidence & confidence

The investment is a fresh, material capex announcement for a mid‑cap listed company; traders may position for a gradual earnings uplift.

Market effects

Sector

Adds to the beverage manufacturing sector's capacity outlook, may pressure peers to announce similar upgrades.

Regional

Supports Western Australian manufacturing activity and local employment figures.

Global

Limited; primarily a company‑specific capex story.

Counterpoint

What could challenge this read

The investment may not translate into near‑term earnings boost, and higher capex could pressure cash flow.

Key entities

company
Coca-Cola Europacific Partners
Bottler and distributor of Coca‑Cola beverages in the Asia‑Pacific, ticker CCEP.
executive
Tom Schiebling
Director of manufacturing at CCEP, quoted on the investment.

Read at source ← All news

OCT 5

$CCEPMed

UBS reiterates Neutral rating on Coca-Cola Europacific Partners stock

UBS reiterated a Neutral rating on Coca-Cola Europacific Partners (CCEP) with a $107.00 price target, citing 5.4% Q3 organic sales growth forecast. The stock trades at $100.50, above InvestingPro’s Fair Value estimate. UBS expects growth in Europe and Asia Pacific, with potential for raised full-year revenue guidance. CCEP reported H1 2026 revenue of EUR 10.7 billion, up 6.1%, and EPS growth of 10.6%. Analysts have mixed views on its valuation and outlook.

investing.com2 min

SEP 24

Low

Coca Cola Europacific Partners (ENXTAM:CCEP) Board Exit Leaves Its Undervalued Case In Focus

Coca-Cola Europacific Partners (CCEP) is under scrutiny after independent non-executive director Nathalie Gaveau resigned, prompting a review of board roles. The company's share price is €88.3, down 6.26% over the past month but up 17.42% year-to-date and 116.77% over five years. Analysts suggest CCEP is 8% undervalued with a fair value of €95.68, citing strong long-term growth prospects in emerging markets and digital investments.

simplywall.st2 min

SEP 14

$CCEPHigh

Transactions in Own Shares

Coca-Cola Europacific Partners (CCEP) repurchased 403,748 ordinary shares from 7 to 11 September 2026, totaling approximately $43.5 million (USD) and £31.2 million (GBP) on US and London trading venues, respectively. The shares were bought as part of the company's EUR 1 billion share buyback program announced in February 2026. The repurchased shares will be cancelled.

investegate.co.uk2 min

SEP 4

$CCEPHigh

CCEP slips as a fresh Wall Street downgrade adds to valuation concerns

Coca-Cola Europacific Partners (CCEP) fell 3.1% after J.P. Morgan re-initiated coverage with an Underweight rating and a $92 price target, citing valuation concerns and potential slowdown in volume growth. The stock has faced scrutiny due to its premium valuation, despite solid first-half 2026 results. Institutional investors have recently adjusted their positions in CCEP.

quiverquant.com2 min

AUG 13

$CCEPMed

UBS Cuts Coca-Cola Europacific Partners to Neutral, Citing Stretched Valuation

UBS downgraded Coca-Cola Europacific Partners (LON: CCEP) to Neutral from Buy, cutting its price target to $107 from $109. Analyst Sanjeet Aujla cited stretched valuation after the stock rose 19% year-to-date and now trades about 20% above European staples peers. UBS said the downgrade is not tied to weaker operations and noted guidance could still be raised.

asktraders.com3 min

AUG 8

$CCEPMedAI 8/10

CCEP (CCEP) Q2 2026 Earnings Call Transcript

Coca-Cola Europacific Partners (CCEP) reported Q2 2026 results on a half-year basis: revenue EUR 10.7B (+6.1%), operating profit EUR 1.5B (+8.1%), operating margin 13.8% (+30 bps), and diluted EPS EUR 2.20 (+10.6%). Free cash flow was EUR 435M in H1; management reaffirmed full-year FCF target of at least EUR 1.7B and completed EUR 600M of a EUR 1B buyback. Risks include Middle East commodity volatility.

aol.com4 min